These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 6752559

  • 1. The antihypertensive effect of captopril in severe essential, renovascular, renal and transplant renovascular hypertension.
    Schwietzer G, Oelkers W.
    Klin Wochenschr; 1982 Aug 16; 60(16):839-46. PubMed ID: 6752559
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differentiation between renovascular and essential hypertension by means of changes in single kidney 99mTc-DTPA clearance induced by angiotensin-converting enzyme inhibition.
    Pedersen EB, Jensen FT, Eiskjaer H, Hansen HH, Jensen JD, Jespersen B, Madsen B, Nielsen HK, Sørensen SS.
    Am J Hypertens; 1989 May 16; 2(5 Pt 1):323-34. PubMed ID: 2655658
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A, Covi G, Capuzzo MG, Lechi C, Minuz P, Delva P, Scuro LA.
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov 16; 21(11):569-74. PubMed ID: 6317579
    [Abstract] [Full Text] [Related]

  • 9. Clinical experience with captopril in the treatment of severe drug-resistant hypertension.
    Raine AE, Ledingham JG.
    Am J Cardiol; 1982 Apr 21; 49(6):1475-9. PubMed ID: 7041586
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Usefulness of converting enzyme inhibitors in diagnosis of renovascular hypertension. I. Comparison of the effect of angiotensin converting enzyme inhibition on blood pressure and plasma renin activity in patients with primary hypertension and renovascular hypertension].
    Posadzy-Małaczyńska A.
    Przegl Lek; 1997 Apr 21; 54(5):314-9. PubMed ID: 9380805
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of the acute effect of a converting enzyme inhibitor, captopril, in normal and hypertensive subjects].
    Mimran A, Laroche B, Targhetta R, Roumieux JL.
    Arch Mal Coeur Vaiss; 1981 Jun 21; 74 Spec No():61-5. PubMed ID: 6794529
    [Abstract] [Full Text] [Related]

  • 13. Long-term efficacy of captopril in renovascular and essential hypertension.
    Case DB, Atlas SA, Marion RM, Laragh JH.
    Am J Cardiol; 1982 Apr 21; 49(6):1440-6. PubMed ID: 6803561
    [Abstract] [Full Text] [Related]

  • 14. Long-term effect of captopril on kidney function in various forms of hypertension.
    Vetter W, Wehling M, Foerster EC, Kuhlmann U, Boerlin HJ, Greminger P, Vetter H.
    Klin Wochenschr; 1984 Aug 01; 62(15):731-7. PubMed ID: 6387263
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.